Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 1, 2019
Previous Article Next Article

Evaluation of novel N′-(3-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors

Author affiliations

Abstract

In an attempt to identify potential new agents that are active against HIV-1 IN, a series of novel coumarin-3-carbohydrazide derivatives were designed and synthesised. The toxicity profiles of these compounds showed that they were non-toxic to human cells and they exhibited promising anti-HIV-1 IN activities with IC50 values in nM range. Also, an accompanying molecular modeling study showed that the compounds bind to the active pocket of the enzyme.

Graphical abstract: Evaluation of novel N′-(3-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors

Back to tab navigation

Supplementary files

Publication details

The article was received on 03 Jul 2018, accepted on 01 Nov 2018 and first published on 10 Dec 2018


Article type: Research Article
DOI: 10.1039/C8MD00328A
Citation: Med. Chem. Commun., 2019,10, 80-88

  •   Request permissions

    Evaluation of novel N′-(3-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors

    O. J. Jesumoroti, Faridoon, D. Mnkandhla, M. Isaacs, H. C. Hoppe and R. Klein, Med. Chem. Commun., 2019, 10, 80
    DOI: 10.1039/C8MD00328A

Search articles by author

Spotlight

Advertisements